Abstract

RIGANTI, Paula et al. Cardiovascular primary prevention and shared decision making. Rev Clin Med Fam [online]. 2019, vol.12, n.3, pp.132-139.  Epub Oct 21, 2019. ISSN 2386-8201.

In recent years, clinical practice guidelines for the prevention of cardiovascular events have lowered the threshold for the prescription of lipid-lowering agents (statins), increasing the population that could receive these medications. Likewise, these guidelines also encourage that doctors and patients discuss together the risks and benefits of the drug treatment, often using the shared decision making (SDM) model. However, the application of this model faces some challenges. The aim of this article was to discuss the difficulties in implementing this model in our setting as regards the primary prevention of cardiovascular events. We used a clinical case as a starting point to illustrate the application of SDM using the tool developed by the Mayo Clinic to aid this process.

Keywords : Decision Making; Primary Prevention; Cardiovascular Diseases, Risk Factors; Hydroxymethylglutaryl-CoA Reductase Inhibitors.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )